Dr Reddy's Laboratories planning mergers and acquisitions to climb up ladder

​​​India contributed about a fifth or ₹4,196 crore of the company's overall sales of ₹21,439 crore in 2021-22, but domestic business has clocked 17% compound annual growth rate in the past four financial years, well above the sector average of 9-10%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3qA2XNV
via IFTTT